165 related articles for article (PubMed ID: 18220331)
1. N(G)-aminoguanidines from primary amines and the preparation of nitric oxide synthase inhibitors.
Martin NI; Beeson WT; Woodward JJ; Marletta MA
J Med Chem; 2008 Feb; 51(4):924-31. PubMed ID: 18220331
[TBL] [Abstract][Full Text] [Related]
2. NG-hydroxyguanidines from primary amines.
Martin NI; Woodward JJ; Marletta MA
Org Lett; 2006 Aug; 8(18):4035-8. PubMed ID: 16928067
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of new sulfur-containing L-arginine-derived inhibitors of nitric oxide synthase.
Ichimori K; Stuehr DJ; Atkinson RN; King SB
J Med Chem; 1999 May; 42(10):1842-8. PubMed ID: 10346937
[TBL] [Abstract][Full Text] [Related]
4. Efficient formation of nitric oxide from selective oxidation of N-aryl N'-hydroxyguanidines by inducible nitric oxide synthase.
Renodon-Cornière A; Boucher JL; Dijols S; Stuehr DJ; Mansuy D
Biochemistry; 1999 Apr; 38(15):4663-8. PubMed ID: 10200153
[TBL] [Abstract][Full Text] [Related]
5. 4,4-Difluorinated analogues of l-arginine and N(G)-hydroxy-l-arginine as mechanistic probes for nitric oxide synthase.
Martin NI; Woodward JJ; Winter MB; Marletta MA
Bioorg Med Chem Lett; 2009 Mar; 19(6):1758-62. PubMed ID: 19230661
[TBL] [Abstract][Full Text] [Related]
6. Inactivation of nitric oxide synthase by substituted aminoguanidines and aminoisothioureas.
Wolff DJ; Gauld DS; Neulander MJ; Southan G
J Pharmacol Exp Ther; 1997 Oct; 283(1):265-73. PubMed ID: 9336332
[TBL] [Abstract][Full Text] [Related]
7. Relationship between the structure of guanidines and N-hydroxyguanidines, their binding to inducible nitric oxide synthase (iNOS) and their iNOS-catalysed oxidation to NO.
Lefèvre-Groboillot D; Boucher JL; Stuehr DJ; Mansuy D
FEBS J; 2005 Jun; 272(12):3172-83. PubMed ID: 15955074
[TBL] [Abstract][Full Text] [Related]
8. KLYP956 is a non-imidazole-based orally active inhibitor of nitric-oxide synthase dimerization.
Symons KT; Massari ME; Nguyen PM; Lee TT; Roppe J; Bonnefous C; Payne JE; Smith ND; Noble SA; Sablad M; Rozenkrants N; Zhang Y; Rao TS; Shiau AK; Hassig CA
Mol Pharmacol; 2009 Jul; 76(1):153-62. PubMed ID: 19364813
[TBL] [Abstract][Full Text] [Related]
9. Studies of neuronal nitric oxide synthase inactivation by diverse suicide inhibitors.
Bryk R; Lubeskie A; Wolff DJ
Arch Biochem Biophys; 1999 Sep; 369(2):243-51. PubMed ID: 10486143
[TBL] [Abstract][Full Text] [Related]
10. Isoform-selective substrates of nitric oxide synthase.
Jia Q; Cai T; Huang M; Li H; Xian M; Poulos TL; Wang PG
J Med Chem; 2003 Jun; 46(12):2271-4. PubMed ID: 12773030
[TBL] [Abstract][Full Text] [Related]
11. Alternative nitric oxide-producing substrates for NO synthases.
Mansuy D; Boucher JL
Free Radic Biol Med; 2004 Oct; 37(8):1105-21. PubMed ID: 15451052
[TBL] [Abstract][Full Text] [Related]
12. Structural requirements for human inducible nitric oxide synthase substrates and substrate analogue inhibitors.
Grant SK; Green BG; Stiffey-Wilusz J; Durette PL; Shah SK; Kozarich JW
Biochemistry; 1998 Mar; 37(12):4174-80. PubMed ID: 9521739
[TBL] [Abstract][Full Text] [Related]
13. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase.
Tiso M; Strub A; Hesslinger C; Kenney CT; Boer R; Stuehr DJ
Mol Pharmacol; 2008 Apr; 73(4):1244-53. PubMed ID: 18178668
[TBL] [Abstract][Full Text] [Related]
14. N-Aryl N'-hydroxyguanidines, a new class of NO-donors after selective oxidation by nitric oxide synthases: structure-activity relationship.
Renodon-Cornière A; Dijols S; Perollier C; Lefevre-Groboillot D; Boucher JL; Attias R; Sari MA; Stuehr D; Mansuy D
J Med Chem; 2002 Feb; 45(4):944-54. PubMed ID: 11831907
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of C5 methylated L-arginine analogues as active site probes for nitric oxide synthase.
Martin NI; Woodward JJ; Winter MB; Beeson WT; Marletta MA
J Am Chem Soc; 2007 Oct; 129(41):12563-70. PubMed ID: 17892291
[TBL] [Abstract][Full Text] [Related]
16. Application of electron spin resonance spin-trapping technique for evaluation of substrates and inhibitors of nitric oxide synthase.
Saito K; Kohno M
Anal Biochem; 2006 Feb; 349(1):16-24. PubMed ID: 16360110
[TBL] [Abstract][Full Text] [Related]
17. Inducible nitric oxide synthase expression and cardiomyocyte dysfunction during sustained moderate ischemia in pigs.
Heinzel FR; Gres P; Boengler K; Duschin A; Konietzka I; Rassaf T; Snedovskaya J; Meyer S; Skyschally A; Kelm M; Heusch G; Schulz R
Circ Res; 2008 Nov; 103(10):1120-7. PubMed ID: 18818404
[TBL] [Abstract][Full Text] [Related]
18. Reactivity of the heme-dioxygen complex of the inducible nitric oxide synthase in the presence of alternative substrates.
Lefèvre-Groboillot D; Boucher JL; Mansuy D; Stuehr DJ
FEBS J; 2006 Jan; 273(1):180-91. PubMed ID: 16367758
[TBL] [Abstract][Full Text] [Related]
19. 1,2-Dihydro-4-quinazolinamines: potent, highly selective inhibitors of inducible nitric oxide synthase which show antiinflammatory activity in vivo.
Tinker AC; Beaton HG; Boughton-Smith N; Cook TR; Cooper SL; Fraser-Rae L; Hallam K; Hamley P; McInally T; Nicholls DJ; Pimm AD; Wallace AV
J Med Chem; 2003 Mar; 46(6):913-6. PubMed ID: 12620067
[TBL] [Abstract][Full Text] [Related]
20. L-arginine analogs as alternate substrates for nitric oxide synthase.
Luzzi SD; Marletta MA
Bioorg Med Chem Lett; 2005 Sep; 15(17):3934-41. PubMed ID: 15993059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
